glp-1 for bulimia Agonist Binge Eating Disorder: Evidence and Safety GLP-1 receptor agonists: A novel

Description

Estos medicamentos deben usarse con precaucin en pacientes con gastroparesia grave y monitorearse la funcin renal, ya que la deshidratacin por efectos gastrointestinales puede provocar lesin renal aguda

However, long-term registry studies, cardiovascular outcome trials, and recent meta-analyses provide a more reassuring picture

In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)

Monitoreo y ajuste continuo: El seguimiento regular del peso, glucosa en sangre (si aplica), presin arterial y otros parmetros metablicos permite deteccin temprana de recuperacin de peso o deterioro glucmico

The mechanism involves multiple factors: reduced caloric intake, blood sugar adjustments, and the neurological effects of GLP-1 receptor activation in the brain